Clinical Trials Browser

Phase 2 × Terminated × vinflunine × Clear all

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Phase 2 Terminated

18 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms